ReviewPathologie (Heidelberg, Germany)2022
[New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis].
Carsten Denkert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it